Pancreatic Cancer Research

ResearcherShanxi Medical UniversityNo recent work listed

Junpeng Meng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5067858506. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression. Co-author DOI 10.15252/embj.2023114558↗
  2. ITGA2 induces STING expression in pancreatic cancer by inducing DNMT1 degradation. Co-author DOI 10.1007/s13402-022-00731-3↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Heshui Wu · 2 shared papers, 2022–2023 · strength 0.38
  2. Dianyun Ren · 2 shared papers, 2022–2023 · strength 0.38
  3. Taoyu Chen · 1 shared paper, 2023 · strength 0.19
  4. Feng Guo · 1 shared paper, 2023 · strength 0.19
  5. Yan Sun · 1 shared paper, 2023 · strength 0.19
  6. Xin Jin · 1 shared paper, 2023 · strength 0.19
  7. Yan Sun · 1 shared paper, 2022 · strength 0.19
  8. Hongkun Cai · 1 shared paper, 2022 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.